Shopping Cart 0
Cart Subtotal
USD 0

The United Laboratories International Holdings Ltd (3933) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

The United Laboratories International Holdings Ltd (3933)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

The United Laboratories International Holdings Ltd (TUL) is a pharmaceutical company that manufactures and sells pharmaceutical products. The company offers products through divisions such as preparation products, intermediate products, capsule products, raw material products, health products and star products. It also provides antibiotics, pharmaceutical raw materials and intermediates, material products and healthcare products. Its intermediates include amino-cephalosporanic acid, amino-penicillin acid, and octylammonium clavulanate. United Laboratories' drug products include amoxicillin capsules, ampicillin capsules, clavulana capsules, levofloxacin hydrochlorid, and cefuroxime axetil tablets, among others. It sells its products through a network of distributors in Europe, North America, East Africa and South East Asia. TUL is headquartered in Hong Kong.

The United Laboratories International Holdings Ltd Key Recent Developments

Jan 06,2017: The United Laboratories International Holdings: Updated Information Of The Group's Products

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

The United Laboratories International Holdings Ltd-Key Facts 6

The United Laboratories International Holdings Ltd-Key Employees 7

The United Laboratories International Holdings Ltd-Key Employee Biographies 8

The United Laboratories International Holdings Ltd-Major Products and Services 9

The United Laboratories International Holdings Ltd-History 10

The United Laboratories International Holdings Ltd-Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Section 2-Company Analysis 12

Company Overview 12

The United Laboratories International Holdings Ltd-Business Description 13

Business Segment: Bulk Medicine 13

Overview 13

Performance 13

Business Segment: Finished Products 13

Overview 13

Performance 13

Business Segment: Intermediate products 13

Overview 13

Performance 14

Geographical Segment: Europe 14

Performance 14

Geographical Segment: Hong Kong 14

Performance 14

Geographical Segment: India 14

Performance 14

Geographical Segment: Middle-East 14

Performance 14

Geographical Segment: Other Asian Regions 14

Performance 14

Geographical Segment: Other Regions 14

Performance 14

Geographical Segment: PRC 15

Performance 15

Geographical Segment: South America 15

Performance 15

The United Laboratories International Holdings Ltd-SWOT Analysis 16

SWOT Analysis-Overview 16

The United Laboratories International Holdings Ltd-Strengths 16

The United Laboratories International Holdings Ltd-Weaknesses 17

The United Laboratories International Holdings Ltd-Opportunities 18

The United Laboratories International Holdings Ltd-Threats 19

The United Laboratories International Holdings Ltd-Key Competitors 20

Section 3-Company Financial Ratios 21

Financial Ratios-Capital Market Ratios 21

Financial Ratios-Annual Ratios 22

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's Lifesciences Financial Deals and Alliances 28

The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

The United Laboratories International Holdings Ltd, Recent Deals Summary 30

Section 5-Company's Recent Developments 31

Jan 06, 2017: The United Laboratories International Holdings: Updated Information Of The Group's Products 31

Section 6-Appendix 32

Methodology 32

Ratio Definitions 32

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

The United Laboratories International Holdings Ltd, Performance Chart (2013-2017) 25

The United Laboratories International Holdings Ltd, Ratio Charts 27

The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29


List Of Table

List of Tables

The United Laboratories International Holdings Ltd, Key Facts 6

The United Laboratories International Holdings Ltd, Key Employees 7

The United Laboratories International Holdings Ltd, Key Employee Biographies 8

The United Laboratories International Holdings Ltd, Major Products and Services 9

The United Laboratories International Holdings Ltd, History 10

The United Laboratories International Holdings Ltd, Other Locations 11

The United Laboratories International Holdings Ltd, Subsidiaries 11

The United Laboratories International Holdings Ltd, Key Competitors 20

The United Laboratories International Holdings Ltd, Ratios based on current share price 21

The United Laboratories International Holdings Ltd, Annual Ratios 22

The United Laboratories International Holdings Ltd, Annual Ratios (Cont...1) 23

The United Laboratories International Holdings Ltd, Annual Ratios (Cont...2) 24

The United Laboratories International Holdings Ltd, Interim Ratios 26

The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

The United Laboratories International Holdings Ltd, Recent Deals Summary 30

Currency Codes 32

Capital Market Ratios 32

Equity Ratios 33

Profitability Ratios 33

Cost Ratios 34

Liquidity Ratios 34

Leverage Ratios 35

Efficiency Ratios 35

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

The United Laboratories International Holdings Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Tianjin Zhongxin Pharmaceutical Group Corp Ltd

Tianjin Tianyao Pharmaceutical Co Ltd

Tasly Pharmaceutical Group Co Ltd

Sinochem Hebei Corp

AccuBioTech Co Ltd